959585-30-9 Usage
General Description
2-(Quinolin-6-yl)propanoic acid, also known as 6-Quinolinylpropionic acid, is a chemical compound with a molecular formula C13H11NO2. It is a derivative of quinoline and is used in the synthesis of various pharmaceuticals and agrochemicals. The compound has been studied for its potential anti-inflammatory and analgesic properties, and it is also used in the development of new drugs for the treatment of various diseases. Additionally, 2-(quinolin-6-yl)propanoic acid has been investigated for its potential use as a chiral auxiliary in organic synthesis reactions. Its versatile properties and potential therapeutic applications make it a valuable chemical compound in pharmaceutical and research industries.
Check Digit Verification of cas no
The CAS Registry Mumber 959585-30-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,5,8 and 5 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 959585-30:
(8*9)+(7*5)+(6*9)+(5*5)+(4*8)+(3*5)+(2*3)+(1*0)=239
239 % 10 = 9
So 959585-30-9 is a valid CAS Registry Number.
InChI:InChI=1/C12H11NO2/c1-8(12(14)15)9-4-5-11-10(7-9)3-2-6-13-11/h2-8H,1H3,(H,14,15)
959585-30-9Relevant articles and documents
Lessons from (S)-6-(1-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3- b ]pyridazin-3-yl)ethyl)quinoline (PF-04254644), an inhibitor of receptor tyrosine kinase c-met with high protein kinase selectivity but broad phosphodiesterase family inhibition lea
Cui, J. Jean,Shen, Hong,Tran-Dubé, Michelle,Nambu, Mitchell,McTigue, Michele,Grodsky, Neil,Ryan, Kevin,Yamazaki, Shinji,Aguirre, Shirley,Parker, Max,Li, Qiuhua,Zou, Helen,Christensen, James
, p. 6651 - 6665 (2013/10/01)
The hepatocyte growth factor (HGF)/c-Met signaling axis is deregulated in many cancers and plays important roles in tumor invasive growth and metastasis. An exclusively selective c-Met inhibitor (S)-6-(1-(6-(1-methyl-1H-pyrazol-4-yl)- [1,2,4]triazolo[4,3-
Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process for Making Them, and Use Thereof for Treating Pain and Other Conditions
-
Page/Page column 56, (2009/07/03)
Vanilloid receptor ligand compounds corresponding to formula I: pharmaceutical compositions containing such compounds, a process for producing such compounds, and methods of using such compounds for treating or inhibiting pain and various other disorders or conditions.